Brind.
  1. Development of innovative medicines for cardiometabolic diseases and treating inflammation in atherosclerotic cardiovascular disease.

Harbour BioMed focuses on solutions for metabolic and cardiovascular diseases.

1 report, 1 independent Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Harbour BioMed focuses on solutions for metabolic and cardiovascular diseases.

Keep exploring

Part of

Development of innovative medicines for cardiometabolic diseases and treating inflammation in atherosclerotic cardiovascular disease. All 2 developments

Coverage

Newest first; wire copies grouped